Literature DB >> 8118532

Outbreak of pertussis in a fully immunized adolescent and adult population.

C A Mink1, N M Sirota, S Nugent.   

Abstract

OBJECTIVE: To evaluate the spread of pertussis in a fully immunized eighth-grade class and the household contacts of two coindex cases of pertussis.
DESIGN: Survey of infected subjects and their contacts was performed using culture, direct fluorescent antibody assay, and serological assays to establish the diagnosis of Bordetella pertussis.
SETTING: Middle-class parochial school. PARTICIPANTS: A volunteer sample of 15 eighth-grade students and 13 household contacts of two identified cases of B pertussis infection.
INTERVENTIONS: All participants had medical histories (including immunization status) and laboratory evaluation for B pertussis infection (including nasopharyngeal specimens and serum samples) obtained initially and 30 days later. After initial evaluation, all subjects received erythromycin ethyl succinate therapy. MAIN OUTCOME MEASURES: Assessment of B pertussis infection as defined by positive nasopharyngeal culture, direct fluorescent antibody, or serological tests.
RESULTS: Laboratory evidence of B pertussis infection was found in eight (47%) of 17 immunized eighth-grade classmates and in three (23%) of 13 household contacts, all of whom were 12 years of age or older.
CONCLUSIONS: Vaccine-induced immunity wanes by early adolescence. These older age groups may be infected with B pertussis and may serve as reservoirs of infection for other susceptible individuals.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8118532     DOI: 10.1001/archpedi.1994.02170020039006

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  15 in total

1.  Analysis with a combination of macrorestriction endonucleases reveals a high degree of polymorphism among Bordetella pertussis isolates in eastern France.

Authors:  G Prevost; F I Freitas; P Stoessel; O Meunier; M Haubensack; H Monteil; J M Scheftel
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

2.  Cellular immunity in adolescents and adults following acellular pertussis vaccine administration.

Authors:  Claudius U Meyer; Fred Zepp; Michael Decker; Martin Lee; Swei-Ju Chang; Joel Ward; Sandra Yoder; Hugues Bogaert; Kathryn M Edwards
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

3.  Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy.

Authors:  G Gabutti; M Bergamini; P Bonanni; M Guido; D Fenoglio; A Giammanco; L Sindoni; C Zotti; V Boddi; F Bamfi; R Severini; A Bechini; S Boccalini; P Crovari
Journal:  Epidemiol Infect       Date:  2008-01-16       Impact factor: 2.451

4.  Pertussis immunization for adolescents: What are we waiting for?

Authors:  S A Halperin
Journal:  Can J Infect Dis       Date:  2001-03

5.  Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine.

Authors:  Natasha B Halasa; Alice O'Shea; Jian R Shi; Bonnie J LaFleur; Kathryn M Edwards
Journal:  J Pediatr       Date:  2008-04-28       Impact factor: 4.406

6.  Pertussis immunization for adolescents: What are we waiting for?

Authors:  S A Halperin
Journal:  Paediatr Child Health       Date:  2001-04       Impact factor: 2.253

Review 7.  Which strategy for pertussis vaccination today?

Authors:  Dorota Z Girard
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 8.  Acellular pertussis vaccine safety and efficacy in children, adolescents and adults.

Authors:  Janet R Casey; Michael E Pichichero
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 9.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

10.  Seroprevalence of pertussis antibody among health care personnel in Spain.

Authors:  Jose-Ramón de Juanes; Angel Gil; Antonio González; María-Pilar Arrazola; María San-Martín; Jesús Esteban
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.